Jan. 2013: Quillivant XR, new ADHD medication from Pfizer.
Dec. 1, 2012: APA approves DSM-5 (pdf)
Oct. 9, 2012: CDC and ADHD Awareness Week
September 13, 2012: CDC releases key findings from ADHD PLAY study.
June 2012: FDA updates safety guidelines for Strattera (atomoxetine) use in individuals with cardiovascular disordersMay 29, 2012: FDA warning on counterfeit Adderall.
March 12-16, 2012: Brain Awareness Week raises awareness of the benefits of brain research.
Feb 7, 2012: FDA Approves Vyvanse for Treatment in Adults
Dec. 15, 2011: HHS updates information, progress on reducing drug shortages
Dec. 12, 2011: FDA updates Safety Review on ADHD medications and cardiovascular risks
Nov. 16, 2011: FDA's new page on ADHD lists NRC as a resource
Nov. 14, 2011: Some ADHD medication shortages continue, says FDA
Oct. 31, 2011: President Issues Executive Order: Reducing Prescription Drug Shortages
Oct. 17, 2011: American Academy of Pediatrics releases new Clinical Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents.
Aug. 22, 2011: CDC reports ADHD data from National Health Interview Study (1998-2009).
July 2011: ADHD cited in first ever World Report on Disability issued by World Health Organization (WHO) and The World Bank
May 23, 2011: Article in Pediatrics, authored by some of CHADD's CDC colleagues, documents rise of ADHD, other developmental disabilities. See CNN interview with lead author Dr. Coleen Boyle.
"Latest News" Archive